Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Left Ventricular Function After Acute Myocardial Infarction. Treatment With the Angiotensin 2-Receptor Blocker Irbesartan

NCT00125645 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.

NCT NCT00125645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Left Ventricular Function After Acute Myocardial Infarction. Treatment With the Angiotensin 2-Receptor Blocker Irbesartan
Lead sponsor
University of Southern Denmark
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2005
Completion date
September 1, 2011
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction